UPDATE 2-Bristol-Myers beats forecasts as hepatitis, arthritis drugs deliver

July 28 (Reuters) - Bristol-Myers Squibb Co reported better-than-expected quarterly results on Thursday, thanks to sales of its treatments for hepatitis C and arthritis, and raised its forecast slightly for full-year profit.